Novel Trace Amine Receptor Associated With Significant Antipsychotic Effects in Schizophrenia
Researchers evaluated the efficacy and safety of trace amine associated receptor-1 agonist SEP-363856 in patients with schizophrenia.
Researchers evaluated the efficacy and safety of trace amine associated receptor-1 agonist SEP-363856 in patients with schizophrenia.